IBM, Public Health Groups Form Global Pandemic Initiative

IBM and over twenty major worldwide public health institutions, including the World Health Organization and the Centers for Disease Control and Prevention, announced the Global Pandemic Initiative, a collaborative effort to help stem the spread of infectious diseases.

With growing concerns over potential outbreaks of new strains of disease, and their ability to spread more easily because of modern transportation, IBM scientists have formed a steering committee with worldwide health organizations and universities to guide efforts to address the issue. Together, they will explore the use of advanced analytical and computer technology as part of a global preparedness program for responding to potential infectious disease outbreaks around the world.

IBM will bring to bear several of its key technologies and is establishing healthcare "Innovation Centers" at the company's worldwide Research laboratories to work with the global healthcare community in this collaborative effort.

"The threat of a pandemic is a definitively global phenomenon," said Samuel J. Palmisano, IBM's chairman and chief executive officer. "Our response must be similarly global, and must rely -- as with so many other major issues we face today -- on open, collaborative innovation. IBM is proud to join with our partners in this effort, grounded in our core value of 'innovation that matters.'"

Central to the effort will be the use of advanced software technologies, elements of which IBM intends to contribute to the open-source community, that are designed to help share information on disease outbreaks electronically and use it to predict how diseases will spread.

Among the technologies that will be used is a software framework IBM developed to allow electronic health information to be more easily shared and mined for trends, such as the outbreak of disease. Called the Interoperable Healthcare Information Infrastructure (IHII), the technology is designed to improve communication and collaboration among medical professionals and researchers by helping them collect and share health data. IBM will expand the role of IHII to include public health issues, responding to global calls for pandemic preparedness by facilitating the sharing of clinical data among medical facilities, laboratories and public health agencies.

IBM also plans to build a community of users around its epidemiological modeling framework, called Spatio-Temporal Epidemiological Modeller (STEM), which can tap the information collected from IHII, along with additional information such as roadmaps, airport locations, travel patterns, and bird migration routes around the world. It will allow users to rapidly develop models for how a disease is likely to geographically spread over time. These models can help public health experts and governmental planners develop more effective preparedness plans.

Ultimately, those plans could include development and distribution of more effective and timely vaccines as IBM taps into knowledge gained through a planned collaborative initiative known as "Project Checkmate," in which IBM and The Scripps Research Institute propose to conduct advanced biological research on influenza viruses. The collaboration is designed to predict the way viruses will mutate over time using advanced predictive techniques running on high performance computing systems, such as IBM's BlueGene supercomputer, allowing effective vaccines to be developed by drug-makers, drawing on the immunology and chemistry expertise at Scripps.

IBM scientists at the company's Research Labs in China, India, Israel, Japan, Switzerland and the U.S. will serve as focal points for the collaboration. Among the members of the Pandemic Initiative steering committee are: US Agency for International Development, Centers for Disease Control and Prevention, World Health Organization, Scripps Research Institute, University of Pittsburgh Medical Center - Center for Biosecurity.

Contact information:
Michael Loughran
IBM Media Relations
914.945.1613
This email address is being protected from spambots. You need JavaScript enabled to view it.

Most Popular Now

New App may Help Caregivers of People Ge…

A new study by investigators from Mass General Brigham showed that a new app they created can help improve the quality of life for caregivers of patients undergoing bone marrow...

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...